The Tumor Immunotherapy and Microenvironment (TIME) research group of the LIH Department of Oncology (DONC) teamed-up with Advanced BioDesign to develop innovative combinatorial immunotherapy approaches. The aim is to potentiate the effectiveness of immunotherapy and provide a ground-breaking approach to treat cancers.

Researchers from the LIH Department of Population Health (DoPH) – namely Dr Ala’a Alkerwi and Dr Maria Ruiz-Castell – Gwenaëlle Le Coroller from the LIH Competence Center for Methodology and Statistics (CCMS) and Prof Laetitia Huiart contributed to a collective study on hypertension with data from the national population-based studies “ORISCAV-LUX” (Observation des Risques et de la Santé Cardiovasculaire au Luxembourg) and “EHESLUX” (European Health Examination Survey in Luxembourg). This research, led by Imperial College London in the framework of the international Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC), aimed to understand whether improvements in hypertension detection, treatment and control have been achieved between 1990 and 2019. Available data on this matter are often subject to methodological differences, making it difficult to compare such aspects among multiple countries. Thus, this study aimed to deliver consistent, solid and comparable data on a national, regional and global level. The results were published in August 2021 in the notorious journal The Lancet.

The Luxembourg Institute of Health is organising this free webinar series “Precision Public Health” to reflect on the transition that is currently happening from traditional Population Health to Precision Public Health. Join us in this weekly 4-part series starting November 16, 2021.

The COVID-19 pandemic sparked an unprecedented mobilisation and collaboration between Research Luxembourg and the government of the Grand Duchy of Luxembourg. In record time, public research institutes and the government launched a series of newly funded research initiatives to respond to the COVID-19 crisis.

Dr Pablo Elias Morande, postdoctoral fellow within the Tumor Stroma Interactions (TSI) research group at the LIH Department of Oncology (DONC), has been awarded financial support in the framework of the European Commission’s “Marie Sklodowska-Curie Individual Fellowships” funding scheme with an exceptional score of 99.2%. The grant will back the scientist’s work on the elucidation of some of the specific mechanisms underlying chronic lymphocytic leukaemia (CLL), thereby advancing the understanding of tumour progression and improving therapy response.

Webinar series: Precision Public Health 2021

Journée de la Recherche « Translationnelle »

WEBINAR: Lecture series Cancer Research: "Role of mRNA Translation in Melanoma Biology and Therapeutics" - Prof Caroline Robert

The Luxembourg Institute of Socio-Economic Research (LISER) and the Luxembourg Institute of Health (LIH) are joining forces in the fight against cardio-metabolic diseases in Luxembourg in the framework of the FNR-funded MET'HOOD (Time-varying residential neighbourhood effects on cardio-metabolic health) project. This multidisciplinary research study is carried out by a team of geographers, epidemiologists, nutritionists and experts in physical activity and sports, with the support of local and national public health and regional planning players.